Vera Therapeutics, Inc. (VERA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Vera Therapeutics, Inc. (VERA)
Company Performance

Current Price

as of Oct 16, 2024

$39.99

P/E Ratio

N/A

Market Cap

$2.19B

Description

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Metrics

Overview

  • HQBrisbane, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerVERA
  • Price$39.99-0.55%

Trading Information

  • Market Cap$2.19B
  • Float75.76%
  • Average Daily Volume (1m)676,581
  • Average Daily Volume (3m)523,043
  • EPS-$2.20

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$33.71M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$35.85M
  • EV$1.65B
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B6.69
Documents
SEC Filings
8-K (2024-10-02)
8-K (2024-08-08)
8-K (2024-07-02)
8-K (2024-06-12)
8-K (2024-05-17)
8-K (2024-05-09)
8-K (2024-03-20)
8-K (2024-01-30)
8-K (2024-01-29)
8-K (2024-01-25)
8-K (2024-01-08)
8-K (2023-12-26)
8-K (2023-11-09)
8-K (2023-08-10)
8-K (2023-06-20)
8-K (2023-05-17)
8-K (2023-05-11)
8-K (2023-03-28)
8-K (2023-03-10)
8-K (2023-02-02)
8-K (2023-02-01)
8-K (2023-01-30)
8-K (2023-01-03)
10-Q (2024-08-08)
10-Q (2024-05-10)
10-Q (2023-11-09)
10-Q (2023-08-10)
10-Q (2023-05-11)
10-K (2024-03-27)
10-K (2023-03-28)
Factset
Factset Business Description
Factset Street Account
Vera Therapeutics upgraded to buy from hold at Jefferies ($11.51, 0.00) (2023-11-10T05:06:25Z)
Vera Therapeutics reports Q3 EPS ($0.45) vs FactSet ($0.52) [8 est, ($0.70)-(0.43)] ($11.52, 0.00) (2023-11-09T13:11:48Z)
Vera Therapeutics presents data from phase 2B Origin study, showing resolution of Hematuria in majority of patients, at ASN ($10.52, 0.00) (2023-11-04T14:14:13Z)